CO72 Bimekizumab: Matching-Adjusted Indirect Comparison (MAIC) to Establish 1-Year Comparative Efficacy in Moderate-to-Severe Hidradenitis Suppurativa (HS)
Abstract
Authors
HB Naik T Tzellos V Piguet L Davis M Mørup V Taieb S Kiri I Munro V Shodimu B Kirby